Cargando…
Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology
Pain is experienced by most cancer patients and represents an important issue in the clinical setting. Breakthrough pain is a transitory flare of pain that occurs in most cancer patients on a background of otherwise controlled persistent pain. Treatment of breakthrough pain is a challenging phenomen...
Autores principales: | Mystakidou, Kyriaki, Tsilika, Eleni, Tsiatas, Marinos, Vlahos, Lambros |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673826/ https://www.ncbi.nlm.nih.gov/pubmed/17722512 |
Ejemplares similares
-
The families evaluation on management, care and disclosure for terminal stage cancer patients
por: Mystakidou, Kyriaki, et al.
Publicado: (2002) -
Efficacy of Oral Transmucosal Fentanyl Citrate for Premedication in Patients for Surgery under General Anesthesia
por: Singh, Raj Bahadur, et al.
Publicado: (2017) -
Oral transmucosal fentanyl citrate analgesia in prehospital trauma care: an observational cohort study
por: Pietsch, Urs, et al.
Publicado: (2023) -
The "Palliative Care Quality of Life Instrument (PQLI)" in terminal cancer patients
por: Mystakidou, Kyriaki, et al.
Publicado: (2004) -
Safety and Efficacy of Oral Transmucosal Fentanyl Citrate Compared to Morphine Sulphate Immediate Release Tablet in Management of Breakthrough Cancer Pain
por: Bhatnagar, Sushma, et al.
Publicado: (2014)